Farzan Filsoufi

PROFESSOR Cardiothoracic Surgery

Print Profile

Email

farzan.filsoufi@mountsinai.org

Specialty

Cardiothoracic Surgery

Education

MD, University of Paris
Fellowship, Cardiothoracic Surg
Brigham and Women's Hospital, Harvard Medical School

Publications

Filsoufi F, Rahmanian PB, Adams DH, Chikwe J, Castillo JG. Predictors, Early and Late Outcome of Respiratory Failure in Contemporary Cardiac Surgery. Chest 2008 Feb 8;.

Filsoufi F, Rahmanian PB, Adams DH, Chikwe J, Carpentier A, Castillo JG. Early and late outcomes of cardiac surgery in patients with moderate to severe preoperative renal dysfunction without dialysis. Interact Cardiovasc Thorac Surg 2008 Feb; 7(1): 90-95.

Filsoufi F, Rahmanian PB, Adams DH, Chikwe J, Silvay G, Castillo JG. Excellent early and late outcomes of aortic valve replacement in people aged 80 and older. J Am Geriatr Soc 2008 Feb; 56(2): 255-261.

Filsoufi F, Rahmanian PB, Adams DH, Kahn RA, Castillo JG. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements. J Cardiothorac Vasc Anesth 2008 Feb; 22(1): 60-66.

Rahmanian PB, Adams DH, Filsoufi F, Chikwe J, Bodian CA, Castillo JG. Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both . Am J Cardiol 2007 Dec; 100(11): 1702-1708.

Rahmanian PB, Adams DH, Filsoufi F, Chikwe J, Castillo JG. Tracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Ann Thorac Surg 2007 Dec; 84(6): 1984-1991.

Filsoufi F, Rahmanian PB, Adams DH, Mechanick JI, Sharma SK, Castillo JG. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2007 Dec; 6(6): 753-758.

Filsoufi F, Rahmanian PB, Adams DH, Chikwe J, Silvay G, Castillo JG. Results and predictors of early and late outcomes of coronary artery bypass graft surgery in octogenarians. J Cardiothorac Vasc Anesth 2007 Dec; 21(6): 784-792.

Rahmanian PB, Adams DH, Castillo JG, Filsoufi F. Video-assisted trans-mitral left ventricular false aneurysm repair with a septal occluder. Eur J Cardiothorac Surg 2007 Nov; 32(5): 799.

Filsoufi F, Rahmanian PB, Adams DH, Pinney S, Broumand SR, Castillo JG. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. J Heart Lung Transplant 2007 Nov; 26(11): 1084-1090.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Filsoufi did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central